New hope for advanced liver cancer: immune drugs after radiation show promise
Disease control
Recruiting now
This study is for people with advanced liver cancer that has spread. It tests whether giving two immune-boosting drugs (durvalumab with or without tremelimumab) after a short course of radiation can help shrink tumors. About 21 participants will receive radiation followed by the …
Phase: PHASE2 • Sponsor: Mary Feng, MD • Aim: Disease control
Last updated May 14, 2026 12:03 UTC